Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Comprehensive exploration of JQ1 and GSK2801 targets in breast cancer using network pharmacology and molecular modeling approaches

Computational and Structural Biotechnology Journal(2023)10.1016/j.csbj.2023.06.003Source: DataRank Database

Comprehensive exploration of JQ1 and GSK2801 targets in breast cancer using network pharmacology and molecular modeling approaches is a research paper published in Computational and Structural Biotechnology Journal (2023). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.28)OA: goldTopics (17)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Dong Pei ORCID,Emily Nissen ORCID,Jeffrey Thompson ORCID,Devin C. Koestler ORCID,Nanda Kumar Yellapu ORCID

Live enrichment

PubMed:38213901 PMC:PMC10781883 OpenAlex:https://openalex.org/W4379259448

National Institute of General Medical Sciences

Grant: P20 GM103418

National Institute of General Medical Sciences

Grant: P20 GM130423

National Cancer Institute

Grant: P30 CA168524

National Institutes of Health

Grant: 3P30CA168524-07S2

Cancer Center Support Grant

National Institutes of Health

Grant: 5P20GM103418-22

Kansas IDeA Network of Biomedical Research Excellence (K-INBRE)

National Institutes of Health

Grant: 5P20GM130423-03

The Kansas Institute for Precision Medicine

National Institutes of Health

FWCI

0.28

Citation Percentile

0.6%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1016/j.csbj.2023.06.003

publisherhttps://doi.org/10.1016/j.csbj.2023.06.003

publisherhttps://api.elsevier.com/content/article/PII:S2001037023002167?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2001037023002167?httpAccept=text/plain

publisherhttps://spj.science.org/doi/pdf/10.1016/j.csbj.2023.06.003

Fields of Study

Computational Drug Discovery MethodsProtein Degradation and InhibitorsBioinformatics and Genomic Networks

Keywords

Computational biologyBreast cancerGeneBiologyInteraction networkCancerBioinformaticsGeneticsdrug targetsNetwork PharmacologyProtein-protein Interaction Network MapsTP248.13-248.65BiotechnologyResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being